Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Florian Cabillic, Audrey Gros, Frédéric Dugay, +14

Journal of Thoracic Oncology

Tumor BiologyImmunohistochemical StudiesMedicineParallel FishCancer Cell Biology +8

Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma

Yann Godbert, Bénédicte Henriques de Figueiredo, F. Bonichon, +9

Journal of Clinical Oncology

Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma

Charline Caumont, Rémi Veillon, Audrey Gros, +3

Lung Cancer

Tumor BiologyEndocrine OncologyNeuroendocrine PhenotypeAlk-rearranged Lung AdenocarcinomaMedicine +8

Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type

Océane Ducharme, M. Beylot‐Barry, Anne Pham‐Ledard, +9

Journal of Investigative Dermatology

Lymphoid NeoplasiaImmunologyPathologyDermatologyAdult T-cell Leukemia-lymphoma +3

Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas

Sarah Menguy, Éric Frison, Martina Prochazkova‐Carlotti, +12

Modern Pathology

Hematological MalignancyLymphoid NeoplasiaMalignant Blood DisorderImmunologyPathology +5

A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type

M. Beylot‐Barry, D. Mermin, Aline Maillard, +20

Journal of Investigative Dermatology

Hematological MalignancyLymphoid NeoplasiaSurgeryDermatologyImmunotherapy +3

Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma

Marius Ilié, Élodie Long-Mira, Elisa Funck‐Brentano, +18

Journal of the American Academy of Dermatology

Routine DetectionMedicineMelanomaPathologyMetastatic Melanoma +8

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer

Nathalie Quénel-Tueux, Marc Debled, Justine Rudewicz, +18

British Journal of Cancer

High‐resolution array‐<scp>CGH</scp> in patients with oculocutaneous albinism identifies new deletions of the <i><scp>TYR</scp>,<scp> OCA</scp>2</i>, and <i><scp>SLC</scp>45A2</i> genes and a complex rearrangement of the <i><scp>OCA</scp>2</i> gene

Fanny Morice‐Picard, Eulalie Lasseaux, Dorothée Cailley, +10

Pigment Cell & Melanoma Research

GeneticsPathologyMolecular BiologyMolecular GeneticsGenomics +19

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity

Sandrine Poglio, Martina Prochazkova‐Carlotti, Floriane Cherrier, +5

Leukemia